Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
TNYA$0.3726+3.20%
Tenaya Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$83.54M
Float & O/S:
Inst Own:
DilutionScan read 36 of Tenaya Therapeutics, Inc.'s SEC filings and found 5 warrant series, 1 ATM program, 2 shelf registrations and 1 completed offering on file for TNYA. The latest dilution event on file is ATM sales on Dec 31, 2025. Analysis updated Oct 6, 2026.
Signal8 Summary
TNYA
Tight cash runway and high burn
Snapshot
Tenaya Therapeutics is a clinical-stage biotech burning cash with a tight runway. It generated no revenue in FY 2025 and spent roughly $69M in free cash flow.
What's Happening Right Now
- : Appointed Eric Hyllengren as Chief Financial Officer effective July 2026 to replace the retiring Hiro Higa.
- : Interim data from the MyPEAK-1 trial showed TN-201 gene therapy resulted in cardiac remodeling and symptom reductions for patients with MYBPC3-associated HCM.
- : Interim data from the RIDGE-1 trial showed TN-401 gene therapy demonstrated a 64% mean reduction in arrhythmia burden for patients with PKP2-associated ARVC.
Raise routes on file: active ATM + effective shelf · latest dilution event 307 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Dec 31, 2025 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Outstanding
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Series A Warrants (March 2025 offering)
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Series B Warrants (March 2025 offering)
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
December 2025 Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2022
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your TNYA trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
